EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 37 / No 2 (June 2005) J Extra Corpor Technol, 37 2 (2005) 196-200 References
Free Access
Issue
J Extra Corpor Technol
Volume 37, Number 2, June 2005
Page(s) 196 - 200
DOI https://doi.org/10.1051/ject/200537196
Published online 15 June 2005
  1. Colman R, Marder V, Salzman E, Hirsh J. Overview of hemostasis. In: Colman R, Marder V, Salzman E, Hirsh J eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practices. Philadelphia: J.B. Lippincott Company; 1994:3–16. [Google Scholar]
  2. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem. 2000;275:35584–91. [CrossRef] [Google Scholar]
  3. Jasani B, Baxter-Smith DC, Donaldson LJ, Selvam A, Sokhi GS. Topical thrombin and control of wound haematoma. Lancet. 1977;2:332–3. [CrossRef] [Google Scholar]
  4. Hashemi K, Donaldson LJ, Freeman JW, Sokhi GS, Gyde OH, Smith HV. The use of topical thrombin to reduce wound haematoma in patients receiving low-dose heparin. Curr Med Res Opin. 1981;7:458–62. [CrossRef] [PubMed] [Google Scholar]
  5. Ofodile FA, Sadana MK. The role of topical thrombin in skin grafting. J Natl Med Assoc. 1991;83:416–8. [Google Scholar]
  6. Codispoti M, Mankad PS. Significant merits of a fibrin sealant in the presence of coagulopathy following paediatric cardiac surgery: randomised controlled trial. Eur J Cardiothorac Surg. 2002;22:200–5. [CrossRef] [PubMed] [Google Scholar]
  7. Amrani DL, Diorio JP, Delmotte Y. Wound healing. Role of commercial fibrin sealants. Ann NY Acad Sci. 2001;936:566–79. [Google Scholar]
  8. Rousou JA, Engelman RM, Breyer RH. Fibrin glue: an effective hemostatic agent for nonsuturable intraoperative bleeding. Ann Thorac Surg. 1984;38:409–10. [CrossRef] [Google Scholar]
  9. Moore M, Burak WEJr, Nelson E, Kearney T, Simmons R, Mayers L, Spotnitz WD. Fibrin Sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg. 2001;192:591–9. [CrossRef] [PubMed] [Google Scholar]
  10. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4–15. [CrossRef] [PubMed] [Google Scholar]
  11. Fennis JP, Stoelinga PJ, Jansen JA. Mandibular reconstruction: a clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg. 2002;31:281–6. [CrossRef] [Google Scholar]
  12. Dugrillon A, Eichler H, Kern S, Kluter H. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg. 2002;31:615–9. [CrossRef] [Google Scholar]
  13. Zehnder J, Leung L. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood. 1990;76:2011–6. [CrossRef] [PubMed] [Google Scholar]
  14. Ortel T, Mercer M, Thames E, Moore K, Lawson J. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001;233:88–96. [CrossRef] [PubMed] [Google Scholar]
  15. Beghi E, Gandolfo C, Ferrarese C, et al. Bovine spongiform encephalopathy and Creutzfeldt–Jacob disease: fact and uncertainties underlying the causal link between animal and human disease. Neurol Sci. 2004;25:122–9. [CrossRef] [PubMed] [Google Scholar]
  16. Clauss A. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 1957;17:237–46. [CrossRef] [PubMed] [Google Scholar]
  17. Yoshida H, Hirozane K, Kamiya A. Adhesive strength of autologous fibrin glue. Biol Pharm Bull. 2000;23:313–7. [CrossRef] [PubMed] [Google Scholar]
  18. Steen V, Holmsen H. Current aspects on human platelet activation and responses. Eur J Haematol. 1987;38:383–99. [Google Scholar]
  19. Leytin V, Mody M, Semple JW, Garvey B, Freedman J. flow cytometric parameters for characterizing platelet activation by measuring p-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations. Biochem Biophys Res Commun. 2000;269:85–90. [CrossRef] [PubMed] [Google Scholar]
  20. Freedman J, Mody M, Lazarus AH, et al. Platelet activation and hypercoagulability following treatment with porcine factor VIII (HYATE:C). Am J Hematol. 2002;69:192–9. [CrossRef] [PubMed] [Google Scholar]
  21. Francischetti IM, Castro HC, Zingali RB, Carlini CR, Guimaraes JA. Bothrops sp. snake venoms: comparison of some biochemical and physicochemical properties and interference in platelet functions. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998;119:21–9. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.